OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
OTUD1 deubiquitinates MADH7, inhibiting endometriosis fibrosis progression, lesion growth, and abdominal inflammation in vitro and in vivo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Fibrosis constitutes the principal pathophysiological mediator of pain and infertility manifestations in endometriosis, and the inhibitory factor of the TGF-β pathway, MADH7, makes a vital impact on the progression of fibrosis. Ovarian tumor domain-containing protein 1 (OTUD1) deubiquitinase binds to the MADH7 protein, although its specific role in endometriosis needs to be investigated. This study is the first to explore the role of OTUD1 in endometriosis and to investigate its impact on the growth of endometriosis lesions in vitro and in vivo, using C57BL/6N female mice and human primary stromal endometriosis cells (HEMCs). Moreover, the obtained results demonstrated that OTUD1 inhibited the expression of fibrosis-related proteins in HEMCs in vitro, and the mechanistic execution of this phenotype was achieved via coordinated deubiquitination coupled with MADH7-mediated transcriptional reprogramming. These events stopped the growth of lesions in vivo and reduced abdominal inflammation. The study demonstrated the critical role of the deubiquitinating enzyme OTUD1 in endometriosis, indicating its potential therapeutic effect on endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model via openalex
- Diagnosis and management of endometriosis via openalex
- Down-regulation of Exosomal miR-214-3p Targeting CCN2 Contributes to Endometriosis Fibrosis and the Role of Exosomes in the Horizontal Transfer of miR-214-3p via openalex
- Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis via openalex
- Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells via openalex
- Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis via openalex
- Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis via openalex
- <scp>LncRNA AFAP1‐AS1</scp> regulates proliferation and apoptosis of endometriosis through activating <scp>STAT3</scp>/<scp>TGF</scp>‐β/Smad signaling via <scp>miR</scp>‐424‐5p via openalex
- The Expression of TGF-β1, SMAD3, ILK and miRNA-21 in the Ectopic and Eutopic Endometrium of Women with Endometriosis via openalex
- Time to redefine endometriosis including its pro-fibrotic nature via openalex
- TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis via openalex
- USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway via openalex
- W2773915736 via openalex
- W2881438881 via openalex
- W3109793392 via openalex
- W3115117553 via openalex
- W3127549549 via openalex
- W4200546702 via openalex
- W4220865020 via openalex
- W4307232774 via openalex
- W4313277461 via openalex
- W4375955530 via openalex
- W4380685156 via openalex
- W4386252421 via openalex
- W4389264895 via openalex
- W4389893618 via openalex
- W4391513354 via openalex
- W1553444759 via openalex
- W6750853143 via openalex
- W1637287381 via openalex
- W1647287056 via openalex
- W1995808441 via openalex
- W2009396278 via openalex
- W2026887261 via openalex
- W2062455763 via openalex
- W2077810230 via openalex
- W2094579915 via openalex
- W2168986165 via openalex
- W2342679639 via openalex
- W2605094983 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-30T00:31:42.381584+00:00
License: CC0
· commercial use OK